SINGLE NUCLEOTIDE POLYMORPHISM FOR THE PROGNOSIS OF HEPATOCELLULAR CARCINOMA

摘要

The present invention relates to a single nucleotide polymorphism (SNP) for the prognosis of hepatocellular carcinoma, wherein the SNP shows a significant correlation with an over-expression of MTA1 which is a useful prognostic factor for prediction of recurrence or poor survival after hepatocellular carcinoma surgery. Therefore, the SNP can be used in developing micro-arrays or diagnosis kits for the prognosis of hepatocellular carcinoma, and in screening drugs for improving prognosis of hepatocellular carcinoma to thereby improve poor prognosis of hepatocellular carcinoma after surgery.